🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Michael Lübbert

University of Freiburg

ORCID: 0000-0003-1186-1650

Also affiliated with University Medical Center Freiburg, Leipzig University

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 6%percentile
0.272Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Clonal architecture in patients with myelodysplastic syndromes and double or minor complex abnormalities: Detailed analysis of clonal composition, involved abnormalities, and prognostic significance

Genes, Chromosomes and Cancer(2018)10.1002/gcc.22667
Top 58%
0.272DataRank
Top 58%4 citations

Francesc Solé, Mar Mallo, Elisa Luño, Jose Cervera, Isabel Granada +18 more

Papers

Driven by 7 papers — median percentile 42. Top paper: “Clinical impact of GATA2 mutations in acute myeloid leukemia patients harboring CEBPA mutations: a study of the AML study group”.

Clinical impact of GATA2 mutations in acute myeloid leukemia patients harboring CEBPA mutations: a study of the AML study group

Leukemia(2016)10.1038/leu.2016.185
N/A
2.6DataRank · unranked
40 citations

A Corbacioglu, V I Gaidzik, P Paschka, D Weber, M Heuser +42 more

Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy

Clinical Epigenetics(2010)10.1007/s13148-010-0012-4
N/A
0.898DataRank · unranked
396 citations

Björn Hackanson, Michael Lübbert, Manfred Jung, Julia M. Wagner

Oncogenic KrasG12D causes myeloproliferation via NLRP3 inflammasome activation

Nature Communications(2020)10.1038/s41467-020-15497-1
N/A
0.750DataRank · unranked
147 citations

Lena Oßwald, Benedikt S. Saller, Susanne Unger, Donatella De Feo, Janaki Manoja Vinnakota +23 more

Nitroreductase‐Mediated Release of Inhibitors of Lysine‐Specific Demethylase 1 (LSD1) from Prodrugs in Transfected Acute Myeloid Leukaemia Cells

ChemBioChem(2020)10.1002/cbic.202000138
N/A
0.470DataRank · unranked
22 citations

Mirjam Hau, Desiree Melanie Redhaber, Gabriele Greve, Dominica Willmann, Simon Steimle +6 more

Development of combination therapies with BTK inhibitors and dasatinib to treat CNS-infiltrating E2A-PBX1+/preBCR+ ALL

Blood Advances(2024)10.1182/bloodadvances.2023011582
N/A
0.330DataRank · unranked
8 citations

Teresa Poggio, Antonella Catalano, Minna Voutilainen, Mari Lahnalampi, Marta Andrade-Martinez +22 more

Clonal architecture in patients with myelodysplastic syndromes and double or minor complex abnormalities: Detailed analysis of clonal composition, involved abnormalities, and prognostic significance

Genes, Chromosomes and Cancer(2018)10.1002/gcc.22667
Top 58%
0.272DataRank
Top 58%4 citations

Francesc Solé, Mar Mallo, Elisa Luño, Jose Cervera, Isabel Granada +18 more

Functional Characterization of Transforming Growth Factor-β Signaling in Dasatinib Resistance and Pre-BCR+ Acute Lymphoblastic Leukemia

Cancers(2023)10.3390/cancers15174328
N/A
0DataRank · unranked
4 citations

Pia Veratti, Kyra Zodel, Gabriele Greve, Miguel Waterhouse, Robert Zeiser +4 more